Single anastomosis sleeve ileal (SASI) bypass is a newly introduced bariatric and metabolic procedure. The present multicenter study aimed to evaluate the efficacy of the SASI bypass in the treatment of patients with morbid obesity and the metabolic syndrome.
This is a retrospective, seven-country, multicenter study on patients with morbid obesity who underwent the SASI bypass. Data regarding patients’ demographics, body mass index (BMI), percentage of total weight loss (%TWL), percentage of excess weight loss (%EWL), and improvement in comorbidities at 12 months postoperatively and postoperative complications were collected.
Among 605 patients who underwent the SASI, 54 were excluded and 551 (390; 70.8% female) were included. At 12 months after the SASI, a significant decrease in the BMI was observed (43.2 ± 12.5 to 31.2 ± 9.7 kg/m2; p < 0.0001). The %TWL was 27.4 ± 13.4 and the %EWL was 63.9 ± 29.5. Among the 279 patients with type 2 diabetes mellitus (T2DM), complete remission was recorded in 234 (83.9%) patients and partial improvement in 43 (15.4%) patients. Eighty-six (36.1%) patients with hypertension, 104 (65%) patients with hyperlipidemia, 37 (57.8%) patients with sleep apnea, and 70 (92.1%) patients with GERD achieved remission. Fifty-six (10.1%) complications and 2 (0.3%) mortalities were recorded. Most complications were minor. All patients had 12 months follow-up.
The SASI bypass is an effective bariatric and metabolic surgery that achieved satisfactory weight loss and improvement in medical comorbidities, including T2DM, hypertension, sleep apnea, and GERD, with a low complication rate.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228–36.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–85.
Favretti F, Cadiere GB, Segato G, et al. Laparoscopic adjustable silicone gastric banding (Lap-Band): how to avoid complications. Obes Surg. 1997;7(4):352–8.
Spak E, Björklund P, Helander H, et al. Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology. 2010;57(5):680.
Santoro S, Milleo FQ, Malzoni CE, et al. Entero hormonal changes after digestive adaptation five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008;18(1):17–26.
Santoro S, Velhote MCP, Malzoni CE, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein. 2003;1(2):99–104.
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.
Angevine KR, Wuescher LM, Andrews K, et al. Menin and GIP are inversely regulated by food intake and diet via PI3/AKT signaling in the proximal duodenum. Nutr Diabetes. 2012;2(12):55.
Higashimoto Y, Opara EC, Liddle RA. Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995;110(2):207–14.
Carr RD, Larsen MO, Winzell MS, et al. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab. 2008;295(4):779–84. https://doi.org/10.1152/ajpendo.90233.2008.
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study. Int J Surg. 2016;34:28–34. https://doi.org/10.1016/j.ijsu.2016.08.018.
Chambers AP, Sandoval DA, Seeley RJ. Integration of satiety signals by the central nervous system. Curr Biol. 2013;23(9):379–88. https://doi.org/10.1016/j.cub.2013.03.020.
Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am. 2001;30(3):765–85.
Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587–606. https://doi.org/10.1007/s11695-015-1645-3.
Emile SH, Elfeki H, Elalfy K, et al. Laparoscopic sleeve gastrectomy then and now: an updated systematic review of the progress and short-term outcomes over the last 5 years. Surg Laparosc Endosc Percutan Tech. 2017;27(5):307–17. https://doi.org/10.1097/SLE.0000000000000418.
Elbanna H, Ghnnam W, Negm A, et al. Impact of preoperative body mass index on the final outcome after laparoscopic sleeve gastrectomy for morbid obesity. Ulus Cerrahi Derg. 2016;32(4):238–43. https://doi.org/10.5152/UCD.2016.3275.
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2019; https://doi.org/10.1097/SLA.0000000000003275. [Ahead of print].
Lauti M, Kularatna M, Hill AG, et al. Weight regain following sleeve gastrectomy-a systematic review. Obes Surg. 2016;26(6):1326–34. https://doi.org/10.1007/s11695-016-2152-x.
Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28:2406–11.
Sista F, Abruzzese V, Clementi M, et al. Resolution of type 2 diabetes after sleeve gastrectomy: a 2-step hypothesis. Surg Obes Relat Dis. 2018;14(3):284–90. https://doi.org/10.1016/j.soard.2017.12.009.
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21(36):10348–57. https://doi.org/10.3748/wjg.v21.i36.10348.
Emile SH. Gastroesophageal reflux disease after sleeve gastrectomy: the need to predict its onset and prevent its consequences. Obes Surg. 2019;29(8):2625–6. https://doi.org/10.1007/s11695-019-03955-9.
Salama TMS, Sabry K, Ghamrini YE. Single anastomosis sleeve ileal bypass: new step in the evolution of bariatric surgeries. J Investig Surg. 2017;30(5):291–6. https://doi.org/10.1080/08941939.2016.1241841.
Emile SH, Elfeki H. Nutritional deficiency after sleeve gastrectomy: a comprehensive literature review. EMJ Gastroenterol. 2017;6(1):99–105.
Swartz DE, Mobley E, Felix EL. Bile reflux after Roux-en-Y gastric bypass: an unrecognized cause of postoperative pain. Surg Obes Relat Dis. 2009;5(1):27–30. https://doi.org/10.1016/j.soard.2008.10.009.
Saarinen T, Räsänen J, Salo J, et al. Bile reflux scintigraphy after mini-gastric bypass. Obes Surg. 2017;27(8):2083–9. https://doi.org/10.1007/s11695-017-2608-7.
Conflict of Interest
The authors declare that they have no conflict of interest.
Statement of Informed Consent
Informed consent was not required for this type of studies (retrospective review of data).
Statement of Human and Animal Rights
This study was conducted in accordance with the declaration of Helsinki. Ethical approval for the study was obtained from the Institutional Ethics Committee.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mahdy, T., Emile, S.H., Madyan, A. et al. Evaluation of the Efficacy of Single Anastomosis Sleeve Ileal (SASI) Bypass for Patients with Morbid Obesity: a Multicenter Study. OBES SURG 30, 837–845 (2020). https://doi.org/10.1007/s11695-019-04296-3
- Morbid obesity